Literature DB >> 21735108

Amoebic liver abscess with negative serologic markers for Entamoeba histolytica: mind the gap!

H Marn1, R Ignatius, E Tannich, G Harms, M Schürmann, S Dieckmann.   

Abstract

A 38-year-old male German traveller returning from Asia presented with fever, night sweats and abdominal complaints. Abdominal ultrasonography revealed several fast-growing abscesses of the liver. Three blood cultures as well as serologic investigations for the detection of antibodies to Entamoeba histolytica, performed on day 3 and 7 after the onset of clinical symptoms, remained negative. Stool microscopy revealed the presence of amoeba cysts compatible with E. histolytica infection. Taking both the amoebic and bacterial etiology of the abscesses into consideration, the patient was treated with metronidazole and ciprofloxacin followed by paromomycin. Antibodies to E. histolytica tested positive shortly after anti-amoebic therapy was initiated. The patient fully recovered, and ultrasound follow-up showed complete resolution of the abscesses within 50 days. This case leads to the conclusion that amoebic liver abscess should be considered despite negative amoeba serology and that ultrasonography is an important diagnostic tool for the early diagnosis of extraintestinal amoebiasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735108     DOI: 10.1007/s15010-011-0157-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Evaluation of a new bicolored latex agglutination test for immunological diagnosis of hepatic amoebiasis.

Authors:  R Robert; C Mahaza; C Bernard; C Buffard; J M Senet
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Evaluation of a rapid enzyme immunoassay for diagnosis of hepatic amoebiasis.

Authors:  L Kraoul; H Adjmi; V Lavarde; J F Pays; C Tourte-Schaefer; C Hennequin
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 3.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 4.  Amebiasis.

Authors:  Bobbi S Pritt; C Graham Clark
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

5.  Features distinguishing amoebic from pyogenic liver abscess: a review of 577 adult cases.

Authors:  S Lodhi; A R Sarwari; M Muzammil; A Salam; R A Smego
Journal:  Trop Med Int Health       Date:  2004-06       Impact factor: 2.622

6.  Development and persistence of antibodies to Entamoeba histolytica in patients with amebic liver abscess. Analysis of 216 cases.

Authors:  J Knobloch; E Mannweiler
Journal:  Am J Trop Med Hyg       Date:  1983-07       Impact factor: 2.345

Review 7.  Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess.

Authors:  Norberto C Chavez-Tapia; Jorge Hernandez-Calleros; Felix I Tellez-Avila; Aldo Torre; Misael Uribe
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  7 in total
  3 in total

Review 1.  Invasive amoebiasis: a review of Entamoeba infections highlighted with case reports.

Authors:  Christopher Skappak; Sarah Akierman; Sara Belga; Kerri Novak; Kris Chadee; Stefan J Urbanski; Deirdre Church; Paul L Beck
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

2.  Amebic liver abscess diagnosed by polymerase chain reaction in 14 returning travelers.

Authors:  Dorothée Vallois; Loïc Epelboin; Feriel Touafek; Denis Magne; Marc Thellier; François Bricaire; Eric Caumes
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

3.  First case of amebic liver abscess 22 years after the first occurrence.

Authors:  Benoît Nespola; Valérie Betz; Julie Brunet; Jean-Charles Gagnard; Yves Krummel; Yves Hansmann; Thierry Hannedouche; Daniel Christmann; Alexander W Pfaff; Denis Filisetti; Bernard Pesson; Ahmed Abou-Bacar; Ermanno Candolfi
Journal:  Parasite       Date:  2015-06-18       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.